PARIS, April 17, 2020 -- MGI, a global life science technology company of BGI Group, has signed an agreement with the Health Ministry of France to provide equipment and materials to enable testing of 2 million people throughout the country for COVID-19. MGI is working with hospitals around France to deliver the urgently needed testing supplies and rapidly scale up capacity to 40,000 tests per day for the population. “I know that I can count on the full mobilization of BGI Group to supp...

MGI has announced a major upgrade for DNBSEQ-G50 with improvements to flexibility, turnaround time and performance. The original FC (Flow Cell) with 300M total reads is upgraded to FCL (Flow Cell Large) with 500M total reads, and a new FCS (Flow Cell Small) has been released with total reads of 100M. In addition, a longer read length of PE150 has been released, and the sequencing chemistry has been optimized to provide shorter turnaround time and better data performance. With this upgrade,...

Abu Dhabi, United Arab Emirates; March 29, 2020: Group 42 (G42), the leading technology company based in Abu Dhabi, and global genomics leader BGI announced today the launch of a new massive-throughput laboratory built to address the need for population-scale detection and diagnosis of COVID-19 in the United Arab Emirates. The lab is capable of conducting tens of thousands RT-PCR tests per day and is the first in the world of this scale to be operational outside of China. The lab showcases the ...

SAN JOSE, CA, March 30, 2020-- Global genomics leader BGI Group is providing SARS-CoV-2 test kits, automated sample preparation equipment and viral RNA extraction reagent to enable the diagnosis of new coronavirus cases in the Kansas City region through an innovative partnership with local business leaders and The University of Kansas Health System. Responding to a request by a group of business leaders to quickly build additional testing ability for their community, BGI immediately mobili...

STOCKHOLM, Sweden and SHENZHEN, China, March 25, 2020- The Swedish Karolinska Institutet (KI) and MGI announced they will jointly build a multi-omics testing laboratory for the detection of novel coronavirus in the Swedish capital Stockholm. The laboratory has two purposes of virus detection and scientific research. It integrates three methods of detection, namely qPCR, high-throughput sequencing, and antibodies. It is equipped with high-throughput sequencer and automated sample preparation ...